Laboratoires Urgo Healthcare
Henry-Xavier Desmarquest serves as the Head of Africa & Latin America Export Zone at Laboratoires URGO Healthcare, where responsibilities include developing existing markets and opening new ones, alongside overseeing two laboratories. Previously, in the role of Head of Eastern Europe Export Zone and Business Development in Latin America, notable achievements include a growth rate of 28% in Eastern Europe and the signing of seven new contracts in Latin America, significantly revitalizing the Chilean market. Desmarquest also has experience managing international operations and CFOs while restructuring the controlling department. Prior positions held at Groupe Rocher include Chief Financial Officer for Stanhome Mexico, where support was provided for substantial growth and profitability, and leading the Controlling department for various subsidiaries. Educational qualifications include an Advanced Master from ESSEC Business School and an Engineer's degree from UniLaSalle.
This person is not in any teams
This person is not in any offices
Laboratoires Urgo Healthcare
2 followers
Les Laboratoires URGO Healthcare font partie du Groupe URGO, groupe français spécialiste du traitement des plaies et de la santé grand public, a été fondé en 1880. Comptant 3 100 collaborateurs, il est présent dans plus de 50 pays dans le monde. URGO a réussi à développer un solide portefeuille de marques à forte notoriété (Juvamine, Alvityl, Sonalto, Super Diet, Ricqlès, Urgo, Mercurochrome…). Il a deux métiers : - le traitement des plaies (cicatrisation avancée et compression) ; - la santé grand-public (premiers soins, complémentaires alimentaires, rhume, allergie, hygiène sexuelle). Le groupe investit fortement dans sa R&D interne et dans des partenariats externes, avec des instituts de recherche et start-ups, pour développer l’innovation.